A Phase 2b study of SAB-142 (study medication) in new-onset Type 1 diabetes

Recruiting Phase 2 NCT07187531

Study Description

A study testing whether SAB-142 (study medication) can slow down the progression of newly diagnosed Type 1 diabetes

Study Details

Registry ID:
NCT07187531
Conditions:
Type 1 Diabetes
Phase:
Phase 2
Target Enrollment:
159 participants
Start Date:
Healthy Volunteers:
No

Study Locations (73 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.org.

View full study details and check eligibility →